| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ESUR prostate MR guidelines 2012.
|
Eur Radiol
|
2012
|
8.86
|
|
2
|
Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
|
J Urol
|
2009
|
3.69
|
|
3
|
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
|
Eur Urol
|
2013
|
3.34
|
|
4
|
Prostate cancer: multiparametric MR imaging for detection, localization, and staging.
|
Radiology
|
2011
|
2.92
|
|
5
|
MR-guided biopsy of the prostate: an overview of techniques and a systematic review.
|
Eur Urol
|
2008
|
2.77
|
|
6
|
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.
|
Lancet Oncol
|
2008
|
2.76
|
|
7
|
Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
|
Radiology
|
2012
|
2.47
|
|
8
|
Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.
|
Radiology
|
2013
|
2.19
|
|
9
|
Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.
|
Radiology
|
2007
|
1.92
|
|
10
|
Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.
|
Eur Urol
|
2012
|
1.84
|
|
11
|
Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis.
|
AJR Am J Roentgenol
|
2014
|
1.77
|
|
12
|
Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer.
|
J Magn Reson Imaging
|
2012
|
1.57
|
|
13
|
Multiparametric MRI of the bladder: ready for clinical routine?
|
AJR Am J Roentgenol
|
2014
|
1.41
|
|
14
|
Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
|
Invest Radiol
|
2008
|
1.26
|
|
15
|
IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.26
|
|
16
|
Feasibility of a pneumatically actuated MR-compatible robot for transrectal prostate biopsy guidance.
|
Radiology
|
2011
|
1.19
|
|
17
|
Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging.
|
Invest Radiol
|
2005
|
1.17
|
|
18
|
Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI.
|
Med Phys
|
2008
|
1.14
|
|
19
|
Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
|
Invest Radiol
|
2014
|
1.12
|
|
20
|
MRI-guided biopsy for prostate cancer detection: a systematic review of current clinical results.
|
Curr Urol Rep
|
2013
|
1.06
|
|
21
|
Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate.
|
Magn Reson Med
|
2004
|
1.03
|
|
22
|
State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.
|
Acta Oncol
|
2011
|
1.03
|
|
23
|
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.
|
Invest Radiol
|
2010
|
1.02
|
|
24
|
Prostate MRI and 3D MR spectroscopy: how we do it.
|
AJR Am J Roentgenol
|
2010
|
1.02
|
|
25
|
Role of MRI in follow-up after focal therapy for prostate carcinoma.
|
AJR Am J Roentgenol
|
2010
|
1.01
|
|
26
|
A systematic review of clinical studies on dynamic magnetic resonance imaging of pelvic organ prolapse: the use of reference lines and anatomical landmarks.
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2009
|
1.00
|
|
27
|
Diffusion and perfusion MR imaging of the prostate.
|
Magn Reson Imaging Clin N Am
|
2008
|
0.99
|
|
28
|
Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T.
|
Magn Reson Med
|
2005
|
0.99
|
|
29
|
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
|
Invest Radiol
|
2012
|
0.97
|
|
30
|
Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer.
|
Invest Radiol
|
2013
|
0.97
|
|
31
|
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.
|
BJU Int
|
2013
|
0.94
|
|
32
|
Dynamic magnetic resonance imaging: reliability of anatomical landmarks and reference lines used to assess pelvic organ prolapse.
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2008
|
0.94
|
|
33
|
Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
|
Eur J Radiol
|
2007
|
0.94
|
|
34
|
The accuracy and safety aspects of a novel robotic needle guide manipulator to perform transrectal prostate biopsies.
|
Med Phys
|
2010
|
0.93
|
|
35
|
MR imaging-guided focal cryoablation in patients with recurrent prostate cancer.
|
Radiology
|
2013
|
0.93
|
|
36
|
Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers.
|
Radiology
|
2005
|
0.92
|
|
37
|
MRI-guided interventions for the treatment of prostate cancer.
|
AJR Am J Roentgenol
|
2012
|
0.91
|
|
38
|
Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
|
Invest Radiol
|
2013
|
0.91
|
|
39
|
POP-Q, dynamic MR imaging, and perineal ultrasonography: do they agree in the quantification of female pelvic organ prolapse?
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2009
|
0.90
|
|
40
|
Changes of prostate gland volume with and without androgen deprivation after intensity modulated radiotherapy - A follow-up study.
|
Radiother Oncol
|
2008
|
0.89
|
|
41
|
Symptoms of pelvic floor dysfunction are poorly correlated with findings on clinical examination and dynamic MR imaging of the pelvic floor.
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2009
|
0.89
|
|
42
|
Diagnosing pubovisceral avulsions: a systematic review of the clinical relevance of a prevalent anatomical defect.
|
Int Urogynecol J
|
2012
|
0.88
|
|
43
|
Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma.
|
Ann Surg Oncol
|
2015
|
0.88
|
|
44
|
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives.
|
Invest Radiol
|
2015
|
0.88
|
|
45
|
Assessment of needle guidance devices for their potential to reduce fluoroscopy time and operator hand dose during C-arm cone-beam computed tomography-guided needle interventions.
|
J Vasc Interv Radiol
|
2013
|
0.87
|
|
46
|
Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience.
|
Radiology
|
2006
|
0.85
|
|
47
|
Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies.
|
Eur Radiol
|
2011
|
0.85
|
|
48
|
In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent.
|
AJR Am J Roentgenol
|
2009
|
0.84
|
|
49
|
Extreme cervical elongation after sacrohysteropexy.
|
Int Urogynecol J
|
2012
|
0.84
|
|
50
|
Initial results of 3-dimensional 1H-magnetic resonance spectroscopic imaging in the localization of prostate cancer at 3 Tesla: should we use an endorectal coil?
|
Invest Radiol
|
2011
|
0.81
|
|
51
|
Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
|
Invest Radiol
|
2007
|
0.80
|
|
52
|
Magnetic resonance-guided biopsy of the prostate: feasibility, technique, and clinical applications.
|
Top Magn Reson Imaging
|
2008
|
0.80
|
|
53
|
[Multiparametric MRI for prostate cancer screening].
|
Ned Tijdschr Geneeskd
|
2009
|
0.79
|
|
54
|
Translabial three-dimensional ultrasonography compared with magnetic resonance imaging in detecting levator ani defects.
|
Obstet Gynecol
|
2014
|
0.79
|
|
55
|
Automated real-time needle-guide tracking for fast 3-T MR-guided transrectal prostate biopsy: a feasibility study.
|
Radiology
|
2014
|
0.78
|
|
56
|
On the importance of modelling organ geometry and boundary conditions for predicting three-dimensional prostate deformation.
|
Comput Methods Biomech Biomed Engin
|
2012
|
0.78
|
|
57
|
Rectal obstruction after a vaginal posterior compartment polypropylene mesh fixed to the sacrospinous ligaments.
|
Int Urogynecol J
|
2011
|
0.78
|
|
58
|
A pictorial overview of pubovisceral muscle avulsions on pelvic floor magnetic resonance imaging.
|
Insights Imaging
|
2013
|
0.77
|
|
59
|
Perineal descent and patients' symptoms of anorectal dysfunction, pelvic organ prolapse, and urinary incontinence.
|
Int Urogynecol J
|
2010
|
0.75
|
|
60
|
FELD better not thinking of metastases only when liver lesions appear after bleomycin-based treatment for non-seminoma testis from metastases.
|
BMC Cancer
|
2013
|
0.75
|
|
61
|
Editorial comment.
|
J Urol
|
2011
|
0.75
|
|
62
|
Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
|
Eur Urol
|
2007
|
0.75
|
|
63
|
The oncologic role of local treatment in primary metastatic prostate cancer.
|
World J Urol
|
2014
|
0.75
|
|
64
|
Feasibility of Multiparametric Magnetic Resonance Imaging of the Prostate at 7 T.
|
Invest Radiol
|
2017
|
0.75
|
|
65
|
Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.
|
BJU Int
|
2014
|
0.75
|
|
66
|
Clinical comparison between a currently available single-loop and an investigational dual-channel endorectal receive coil for prostate magnetic resonance imaging: a feasibility study at 1.5 and 3 T.
|
Invest Radiol
|
2014
|
0.75
|
|
67
|
Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
|
J Magn Reson Imaging
|
2011
|
0.75
|